NASDAQ:TWST | Free Cash Flow | Twist Bioscience Corp

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-09-30 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$24.81M$9.97M-$34.79M
2025-09-30-$11.81M$12.43M-$24.24M
2024-12-31-$21.43M$2.27M-$23.7M
2024-09-30-$15.32M$2M-$17.32M
2023-12-31-$22.97M$1.51M-$24.48M
2023-09-30-$20.7M$2.39M-$23.1M
2022-12-31-$54.07M$11.82M-$65.89M
2022-09-30-$1.27M$16.46M-$17.73M
2021-12-31-$46.65M$12.78M-$59.44M
2021-09-30-$34.8M$8.09M-$42.89M
2020-12-31-$24.93M$3.63M-$28.56M
2020-09-30-$25.2M$2.23M-$27.43M
2019-12-31-$34.91M$2.06M-$36.97M
2019-09-30-$23.36M$3.89M-$27.25M
2018-12-31-$21.68M$1.92M-$23.61M
2018-09-30-$16.7M$1.05M-$17.74M
2017-12-31-$16.02M$1.51M-$17.53M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$47.63M$28M-$75.63M
2024-09-30-$64.09M$5.08M-$69.17M
2023-09-30-$142.47M$27.78M-$170.25M
2022-09-30-$124.39M$101.86M-$226.24M
2021-09-30-$112.24M$27.06M-$139.31M
2020-09-30-$142.26M$9.87M-$152.12M
2019-09-30-$87.94M$14.76M-$102.69M
2018-09-30-$66.16M$3.69M-$69.85M
2017-09-30-$51.3M$6.59M-$57.9M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.